Analysts at Oppenheimer provided their views on CDK Global, Inc. (NASDAQ:CDK) ahead of the company’s Q3 earnings report, stating that the company is significantly better positioned than it has been in years.

According to the brokerage, the business continues to perform well and Q3 could mark the 13th consecutive quarter of site count growth. Efforts to improve the customer experience have worked. The company added significant capabilities to its product offering and shed lower-margin, non-core businesses. R&D and software spending appears to have leveled off at 10% of revenues and is sufficient to support the expansion of recent acquisitions, including Salty and Roadster. Furthermore, around 90% of revenues are non-transaction-related, which insulates the company in an auto slowdown.